Clinical trial
Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion…
NCT01709838 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT01709838 |
|---|---|
| Title | Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia |
| Official title | An Open Label, Multi-center, Efficacy and Safety Study of Deferasirox in Iron Overloaded Patients With Non-transfusion Dependent Thalassemia |
| Acronym | THETIS |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Non-transfusion Dependent Thalassemia |
| Intervention type | Drug |
| Interventions | deferasirox |
| Enrollment | 134 |
| Start date | Dec 6, 2012 |
| Primary completion | Jan 3, 2015 |
| Completion | Jan 17, 2019 |
| First posted | Oct 18, 2012 |
| Last update posted | Oct 2, 2019 |
| Countries | China, Greece, Italy, Lebanon, Thailand, Tunisia, Turkey (Türkiye), United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: